학술논문

Gemcitabine versus FOLFIRINOX in patients with advanced pancreatic adenocarcinoma hENT1-positive: everything was not too bad back when everything seemed worse
Document Type
Article
Source
In: Clinical and Translational Oncology. (Clinical and Translational Oncology, 1 October 2016, 18(10):988-995)
Subject
Language
English
ISSN
16993055
1699048X